Liu M - Search Results

1

Hypofractionated versus conventionally fractionated image-guided volumetric-modulated arc radiotherapy for localized prostate cancer: a phase II randomized trial from China.

Zhong QZ, Xia X, Gao H, Xu YG, Zhao T, Wu QH, Wang D, Lin HL, Sha XY, Liu M, Li GF. Zhong QZ, et al. Among authors: liu m. Aging (Albany NY). 2021 Feb 26;13(5):6936-6944. doi: 10.18632/aging.202551. Epub 2021 Feb 26. Aging (Albany NY). 2021. PMID: 33653964 Free PMC article. Clinical Trial.

2

All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation.

Guo XX, Guo ZH, Lu JS, Xie WS, Zhong QZ, Sun XD, Wang XM, Wang JY, Liu M, Zhao LY. Guo XX, et al. Among authors: liu m. Nanoscale. 2021 Sep 2;13(34):14525-14537. doi: 10.1039/d1nr03869a. Nanoscale. 2021. PMID: 34473816

3

Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification.

Tian Z, Meng L, Wang X, Wang X, Ma T, Wang M, Zhong Q, Zhang Y, Liu M. Tian Z, et al. Among authors: liu m. Front Oncol. 2021 Jun 10;11:706236. doi: 10.3389/fonc.2021.706236. eCollection 2021. Front Oncol. 2021. PMID: 34178701 Free PMC article.

4

Correction: All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation.

Guo XX, Guo ZH, Lu JS, Xie WS, Zhong QZ, Sun XD, Wang XM, Wang JY, Liu M, Zhao LY. Guo XX, et al. Among authors: liu m. Nanoscale. 2022 May 5;14(17):6670. doi: 10.1039/d2nr90081e. Nanoscale. 2022. PMID: 35466988

5

MicroRNA-20b Downregulates HIF-1α and Inhibits the Proliferation and Invasion of Osteosarcoma Cells.

Liu M, Wang D, Li N. Liu M, et al. Oncol Res. 2016;23(5):257-66. doi: 10.3727/096504016X14562725373752. Oncol Res. 2016. PMID: 27098149 Free PMC article.

6

Comparison of radical prostatectomy versus conservative treatment in localized prostate cancer: systematic review and meta-analysis.

Tian Z, Wang X, Wu P, Shi T, Liu M. Tian Z, et al. Among authors: liu m. J BUON. 2019 Jan-Feb;24(1):239-248. J BUON. 2019. PMID: 30941976 Free article.

7

A comparative study of Gaussian and non-Gaussian diffusion models for differential diagnosis of prostate cancer with in-bore transrectal MR-guided biopsy as a pathological reference.

Li C, Chen M, Wan B, Yu J, Liu M, Zhang W, Wang J. Li C, et al. Among authors: liu m. Acta Radiol. 2018 Nov;59(11):1395-1402. doi: 10.1177/0284185118760961. Epub 2018 Feb 27. Acta Radiol. 2018. PMID: 29486596

8

Histogram analysis in prostate cancer: a comparison of diffusion kurtosis imaging model versus monoexponential model.

Jiang Y, Li C, Liu Y, Shi K, Zhang W, Liu M, Chen M. Jiang Y, et al. Among authors: liu y, liu m. Acta Radiol. 2020 Oct;61(10):1431-1440. doi: 10.1177/0284185120901504. Epub 2020 Feb 2. Acta Radiol. 2020. PMID: 32008343

9

Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger Than 60 Years. Letter.

Guo B, Liu M. Guo B, et al. Among authors: liu m. J Urol. 2021 May;205(5):1530-1531. doi: 10.1097/JU.0000000000001636. Epub 2021 Jan 22. J Urol. 2021. PMID: 33480809 No abstract available.

10

Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.

Cui Y, Han S, Liu M, Wu PY, Zhang W, Zhang J, Li C, Chen M. Cui Y, et al. Among authors: liu m. J Magn Reson Imaging. 2020 Aug;52(2):552-564. doi: 10.1002/jmri.27075. Epub 2020 Feb 6. J Magn Reson Imaging. 2020. PMID: 32027071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,473 results

Search Page

Filters